124 related articles for article (PubMed ID: 15279582)
1. Engineered killer mimotopes: new synthetic peptides for antimicrobial therapy.
Magliani W; Conti S; Salati A; Arseni S; Ravanetti L; Frazzi R; Polonelli L
Curr Med Chem; 2004 Jul; 11(13):1793-800. PubMed ID: 15279582
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic activity of an engineered synthetic killer antiidiotypic antibody fragment against experimental mucosal and systemic candidiasis.
Polonelli L; Magliani W; Conti S; Bracci L; Lozzi L; Neri P; Adriani D; De Bernardis F; Cassone A
Infect Immun; 2003 Nov; 71(11):6205-12. PubMed ID: 14573638
[TBL] [Abstract][Full Text] [Related]
3. From Pichia anomala killer toxin through killer antibodies to killer peptides for a comprehensive anti-infective strategy.
Polonelli L; Magliani W; Ciociola T; Giovati L; Conti S
Antonie Van Leeuwenhoek; 2011 Jan; 99(1):35-41. PubMed ID: 20714805
[TBL] [Abstract][Full Text] [Related]
4. From yeast killer toxins to antibiobodies and beyond.
Magliani W; Conti S; Travassos LR; Polonelli L
FEMS Microbiol Lett; 2008 Nov; 288(1):1-8. PubMed ID: 18785931
[TBL] [Abstract][Full Text] [Related]
5. Biotechnological approaches to the production of idiotypic vaccines and antiidiotypic antibiotics.
Magliani W; Conti S; Salati A; Arseni S; Ravanetti L; Frazzi R; Polonelli L
Curr Pharm Biotechnol; 2003 Apr; 4(2):91-7. PubMed ID: 12678884
[TBL] [Abstract][Full Text] [Related]
6. Protective antifungal yeast killer toxin-like antibodies.
Magliani W; Conti S; Frazzi R; Ravanetti L; Maffei DL; Polonelli L
Curr Mol Med; 2005 Jun; 5(4):443-52. PubMed ID: 15978000
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic potential of yeast killer toxin-like antibodies and mimotopes.
Magliani W; Conti S; Salati A; Vaccari S; Ravanetti L; Maffei DL; Polonelli L
FEMS Yeast Res; 2004 Oct; 5(1):11-8. PubMed ID: 15381118
[TBL] [Abstract][Full Text] [Related]
8. In vitro acanthamoebicidal activity of a killer monoclonal antibody and a synthetic peptide.
Fiori PL; Mattana A; Dessì D; Conti S; Magliani W; Polonelli L
J Antimicrob Chemother; 2006 May; 57(5):891-8. PubMed ID: 16507561
[TBL] [Abstract][Full Text] [Related]
9. Killer anti-idiotypes in the control of fungal infections.
Magliani W; Conti S; Arseni S; Frazzi R; Salati A; Polonelli L
Curr Opin Investig Drugs; 2001 Apr; 2(4):477-9. PubMed ID: 11566002
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic potential of antiidiotypic single chain antibodies with yeast killer toxin activity.
Magliani W; Conti S; de Bernardis F; Gerloni M; Bertolotti D; Mozzoni P; Cassone A; Polonelli L
Nat Biotechnol; 1997 Feb; 15(2):155-8. PubMed ID: 9035141
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of a monoclonal killer anti-idiotypic antibody and a synthetic killer peptide against oral isolates of Candida spp. differently susceptible to conventional antifungals.
Manfredi M; McCullough MJ; Conti S; Polonelli L; Vescovi P; Al-Karaawi ZM; Porter SR
Oral Microbiol Immunol; 2005 Aug; 20(4):226-32. PubMed ID: 15943767
[TBL] [Abstract][Full Text] [Related]
12. Yeast killer toxin-like candidacidal Ab6 antibodies elicited through the manipulation of the idiotypic cascade.
Polonelli L; Beninati C; Teti G; Felici F; Ciociola T; Giovati L; Sperindè M; Lo Passo C; Pernice I; Domina M; Arigò M; Papasergi S; Mancuso G; Conti S; Magliani W
PLoS One; 2014; 9(8):e105727. PubMed ID: 25162681
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of monoclonal and recombinant yeast killer toxin-like antibodies against antibiotic-resistant gram-positive cocci.
Conti S; Magliani W; Arseni S; Dieci E; Frazzi R; Salati A; Varaldo PE; Polonelli L
Mol Med; 2000 Jul; 6(7):613-9. PubMed ID: 10997342
[TBL] [Abstract][Full Text] [Related]
14. Anti-beta-glucan-like immunoprotective candidacidal antiidiotypic antibodies.
Magliani W; Conti S; Giovati L; Maffei DL; Polonelli L
Front Biosci; 2008 May; 13():6920-37. PubMed ID: 18508705
[TBL] [Abstract][Full Text] [Related]
15. Effect of a killer toxin of Pichia anomala to Pneumocystis. Perspectives in the control of pneumocystosis.
Séguy N; Polonelli L; Dei-Cas E; Cailliez JC
FEMS Immunol Med Microbiol; 1998 Sep; 22(1-2):145-9. PubMed ID: 9792073
[TBL] [Abstract][Full Text] [Related]
16. Production of an engineered killer peptide in Nicotiana benthamiana by using a potato virus X expression system.
Donini M; Lico C; Baschieri S; Conti S; Magliani W; Polonelli L; Benvenuto E
Appl Environ Microbiol; 2005 Oct; 71(10):6360-7. PubMed ID: 16204558
[TBL] [Abstract][Full Text] [Related]
17. Antibodies as crypts of antiinfective and antitumor peptides.
Magliani W; Conti S; Cunha RL; Travassos LR; Polonelli L
Curr Med Chem; 2009; 16(18):2305-23. PubMed ID: 19519392
[TBL] [Abstract][Full Text] [Related]
18. Peptide derived from anti-idiotypic single-chain antibody is a potent antifungal agent compared to its parent fungicide HM-1 killer toxin peptide.
Kabir ME; Karim N; Krishnaswamy S; Selvakumar D; Miyamoto M; Furuichi Y; Komiyama T
Appl Microbiol Biotechnol; 2011 Dec; 92(6):1151-60. PubMed ID: 21691785
[TBL] [Abstract][Full Text] [Related]
19. Interfaces of the yeast killer phenomenon.
Polonelli L; Conti S; Gerloni M; Magliani W; Chezzi C; Morace G
Crit Rev Microbiol; 1991; 18(1):47-87. PubMed ID: 1854433
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal yeast killer toxin-like candidacidal anti-idiotypic antibodies.
Polonelli L; Séguy N; Conti S; Gerloni M; Bertolotti D; Cantelli C; Magliani W; Cailliez JC
Clin Diagn Lab Immunol; 1997 Mar; 4(2):142-6. PubMed ID: 9067647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
